Actinium Pharmaceuticals, Inc. (ATNM) Ownership

$1.43

$0.02 (-1.38%)
Last update: 04:00 PM EST
Day's range
$1.41
Day's range
$1.54

Actinium Pharmaceuticals, Inc. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
VANGUARD GROUP INC 11/07/2025 1.38 M $2.22 M   0.93% 4.44%
MILLENNIUM MANAGEMENT LLC 11/14/2025 624.70 K $999.52 K   -5.82% 2.00%
ACADIAN ASSET MANAGEMENT LLC 11/13/2025 489.58 K $782.00 K   -0.48% 1.57%
BLACKROCK, INC. 11/12/2025 363.49 K $581.58 K   -22.28% 1.17%
GEODE CAPITAL MANAGEMENT, LLC 11/12/2025 328.42 K $525.63 K   -0.39% 1.05%
RENAISSANCE TECHNOLOGIES LLC 11/13/2025 288.63 K $461.81 K   37.77% 0.93%
TWO SIGMA INVESTMENTS, LP 11/14/2025 234.29 K $374.87 K   403.37% 0.75%
GAGNON SECURITIES LLC 11/03/2025 226.26 K $362.01 K   -0.16% 0.73%
TWO SIGMA ADVISERS, LP 11/14/2025 196.38 K $314.20 K   100.00% 0.63%
CITADEL ADVISORS LLC 11/14/2025 126.62 K $202.58 K   130.18% 0.41%
STATE STREET CORP 11/14/2025 126.22 K $201.94 K   -43.15% 0.40%
GEN-WEALTH PARTNERS INC 11/14/2025 109.38 K $175.01 K   100.00% 0.35%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 11/14/2025 105.44 K $168.70 K   26.93% 0.34%
JANE STREET GROUP, LLC 11/14/2025 93.02 K $148.84 K   -57.39% 0.30%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 11/14/2025 40.00 K $64.00 K   0.00% 0.13%
NORTHERN TRUST CORP 11/14/2025 35.90 K $57.43 K   -40.17% 0.12%
DIMENSIONAL FUND ADVISORS LP 11/12/2025 34.92 K $55.88 K   0.00% 0.11%
VONTOBEL HOLDING LTD. 10/15/2025 30.00 K $48.00 K   0.00% 0.10%
MARSHALL WACE, LLP 11/13/2025 26.34 K $42.14 K   -73.16% 0.08%
QUBE RESEARCH & TECHNOLOGIES LTD 11/14/2025 25.72 K $41.16 K   -48.49% 0.08%
CITADEL ADVISORS LLC 11/14/2025 25.10 K $40.16 K   -35.97% 0.08%
CALLAN FAMILY OFFICE, LLC 11/04/2025 23.60 K $37.77 K   0.00% 0.08%
MAYPORT, LLC 11/20/2025 22.00 K $35.20 K   100.00% 0.07%
FMR LLC 11/13/2025 21.10 K $33.76 K   -13.23% 0.07%
NORTH STAR ASSET MANAGEMENT INC 11/10/2025 20.00 K $32.00 K   0.00% 0.06%
XTX TOPCO LTD 11/14/2025 19.96 K $31.94 K   50.66% 0.06%
WELLS FARGO & COMPANY/MN 11/13/2025 19.80 K $31.68 K   259.48% 0.06%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 11/14/2025 17.20 K $27.52 K   100.00% 0.06%
AQR CAPITAL MANAGEMENT LLC 11/14/2025 16.81 K $26.89 K   -78.24% 0.05%
UBS GROUP AG 11/13/2025 14.58 K $23.32 K   -43.04% 0.05%
CETERA INVESTMENT ADVISERS 11/14/2025 14.49 K $23.19 K   100.00% 0.05%
RUSSELL INVESTMENTS GROUP, LTD. 11/13/2025 13.34 K $21.34 K   -3.02% 0.04%
INTREPID FINANCIAL PLANNING GROUP LLC 11/13/2025 12.50 K $20.00 K   0.00% 0.04%
POINT72 ASIA (SINGAPORE) PTE. LTD. 11/14/2025 10.30 K $16.47 K   -51.07% 0.03%
LEVEL FOUR ADVISORY SERVICES, LLC 11/12/2025 10.00 K $16.00 K   100.00% 0.03%
ADVISOR GROUP HOLDINGS, INC. 11/14/2025 7.15 K $12.23 K   0.00% 0.02%
ROYAL BANK OF CANADA 11/14/2025 5.72 K $9.00 K   0.94% 0.02%
MORGAN STANLEY 11/14/2025 4.72 K $7.55 K   -89.44% 0.02%
ROCKEFELLER CAPITAL MANAGEMENT L.P. 11/14/2025 4.50 K $7.20 K   100.00% 0.01%
ADVISORY SERVICES NETWORK, LLC 11/18/2025 2.46 K $3.94 K   100.00% 0.01%
STEWARD PARTNERS INVESTMENT ADVISORY, LLC 11/12/2025 2.17 K $3.47 K   8.30% 0.01%
FEDERATED HERMES, INC. 11/03/2025 1.93 K $3.08 K   -63.82% 0.01%
JPMORGAN CHASE & CO 11/26/2025 1.56 K $2.50 K   -91.61% 0.01%
CWM, LLC 10/15/2025 1.40 K $2.00 K   -81.51% 0.00%
CITIGROUP INC 11/10/2025 1.29 K $2.06 K   -91.50% 0.00%
NISA INVESTMENT ADVISORS, LLC 10/23/2025 958 $1.53 K   0.00% 0.00%
NATIONAL BANK OF CANADA /FI/ 11/14/2025 855 $1.37 K   0.00% 0.00%
BANK OF AMERICA CORP /DE/ 11/14/2025 648 $1.04 K   -97.50% 0.00%
TOWER RESEARCH CAPITAL LLC (TRC) 11/14/2025 555 $888   -77.60% 0.00%
GROUP ONE TRADING, L.P. 11/12/2025 547 $875   0.00% 0.00%

Actinium Pharmaceuticals, Inc. institutional Ownership - FAQ's

During the previous two years, 84 institutional investors and hedge funds held shares of Actinium Pharmaceuticals, Inc.. The most heavily invested institutionals were:

VANGUARD GROUP INC: 1.38 M

MILLENNIUM MANAGEMENT LLC: 624,697

ACADIAN ASSET MANAGEMENT LLC: 489,577

BlackRock, Inc.: 363,486

GEODE CAPITAL MANAGEMENT, LLC: 328,419

RENAISSANCE TECHNOLOGIES LLC: 288,630

16.50% of Actinium Pharmaceuticals, Inc. stock is owned by institutional investors.

Institutional investors have bought a total of 8.38 M shares in the last 24 months. This purchase volume represents approximately $11.98 M in transactions.